{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T04:04:36Z","timestamp":1789617876933,"version":"build-2803163510"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Purinergic Signalling"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s11302-026-10183-1","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T03:38:14Z","timestamp":1789616294000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The role of natural polyphenols in purinergic signaling: from molecular mechanisms to physiological implications"],"prefix":"10.1007","volume":"22","author":[{"given":"Ujjawal","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simran","family":"Soni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bunty","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deeksha","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damandeep","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shafiul","family":"Haque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hardeep","family":"SinghTuli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ginpreet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Sak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,17]]},"reference":[{"key":"10183_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1058371","volume":"13","author":"J Kaur","year":"2023","unstructured":"Kaur J, Dora S (2023) Purinergic signaling: diverse effects and therapeutic potential in cancer. Front Oncol 13:1058371. https:\/\/doi.org\/10.3389\/fonc.2023.1058371","journal-title":"Front Oncol"},{"issue":"1","key":"10183_CR2","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s11302-022-09905-y","volume":"19","author":"L Wang","year":"2023","unstructured":"Wang L, Li YJ, Yang X, Yang B, Zhang X, Zhang J, Zhang Q, Cheng XD, Wang JH, Yu NW (2023) Purinergic signaling: a potential therapeutic target for ischemic stroke. Purinergic Signal 19(1):173\u2013183. https:\/\/doi.org\/10.1007\/s11302-022-09905-y","journal-title":"Purinergic Signal"},{"key":"10183_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.1006384","volume":"10","author":"M Zanoni","year":"2022","unstructured":"Zanoni M, Pegoraro A, Adinolfi E, De Marchi E (2022) Emerging roles of purinergic signaling in anti-cancer therapy resistance. Front Cell Dev Biol 10:1006384. https:\/\/doi.org\/10.3389\/fcell.2022.1006384","journal-title":"Front Cell Dev Biol"},{"issue":"5","key":"10183_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/biom13050856","volume":"13","author":"M Boccazzi","year":"2023","unstructured":"Boccazzi M, Raffaele S, Zanettin T, Abbracchio MP, Fumagalli M (2023) Altered purinergic signaling in neurodevelopmental disorders: focus on P2 receptors. Biomolecules 13(5):856. https:\/\/doi.org\/10.3390\/biom13050856","journal-title":"Biomolecules"},{"issue":"1","key":"10183_CR5","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s11302-022-09856-4","volume":"19","author":"Y Zhuang","year":"2023","unstructured":"Zhuang Y, Yu ML, Lu SF (2023) Purinergic signaling in myocardial ischemia-reperfusion injury. Purinergic Signal 19(1):229\u2013243. https:\/\/doi.org\/10.1007\/s11302-022-09856-4","journal-title":"Purinergic Signal"},{"key":"10183_CR6","doi-asserted-by":"publisher","unstructured":"Carvalho-Barbosa N, Zeidler JD, Savio LEB, Coutinho-Silva R (2023) Purinergic signaling in the battlefield of viral infections. Purinergic Signal. https:\/\/doi.org\/10.1007\/s11302-023-09981-8","DOI":"10.1007\/s11302-023-09981-8"},{"issue":"5","key":"10183_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.359","volume":"4","author":"Y Ai","year":"2023","unstructured":"Ai Y, Wang H, Liu L, Qi Y, Tang S, Tang J, Chen N (2023) Purine and purinergic receptors in health and disease. MedComm (2020) 4(5):e359. https:\/\/doi.org\/10.1002\/mco2.359","journal-title":"MedComm (2020)"},{"key":"10183_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1181948","volume":"14","author":"H Che","year":"2023","unstructured":"Che H, Wang Y, Lao J, Deng Y, Xu C, Yin H, Tang Z, Huang Y, Xu H (2023) Role of purinergic signalling in obesity-associated end-organ damage: focus on the effects of natural plant extracts. Front Endocrinol (Lausanne) 14:1181948. https:\/\/doi.org\/10.3389\/fendo.2023.1181948","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"10183_CR9","doi-asserted-by":"publisher","first-page":"676","DOI":"10.3390\/molecules22040676.PMID:28441750;PMCID:PMC6154612","volume":"22","author":"J Stockwell","year":"2017","unstructured":"Stockwell J, Jakova E, Cayabyab FS (2017) Adenosine A1 and A2A Receptors in the Brain: Current Research and Their Role in Neurodegeneration. Molecules 22(4):676. https:\/\/doi.org\/10.3390\/molecules22040676.PMID:28441750;PMCID:PMC6154612","journal-title":"Molecules"},{"issue":"5","key":"10183_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25052495","volume":"25","author":"C Acu\u00f1a-Castillo","year":"2024","unstructured":"Acu\u00f1a-Castillo C, Escobar A, Garc\u00eda-G\u00f3mez M, Bachelet VC, Huidobro-Toro JP, Sauma D, Barrera-Avalos C (2024) P2X7 receptor in dendritic cells and macrophages: implications in antigen presentation and T lymphocyte activation. Int J Mol Sci 25(5):2495. https:\/\/doi.org\/10.3390\/ijms25052495","journal-title":"Int J Mol Sci"},{"key":"10183_CR11","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.92829","volume":"12","author":"D Sheng","year":"2024","unstructured":"Sheng D, Yue CX, Jin F, Wang Y, Ichikawa M, Yu Y, Guo CR, Hattori M (2024) Structural insights into the orthosteric inhibition of P2X receptors by non-ATP analog antagonists. Elife 12:RP92829","journal-title":"Elife"},{"issue":"6","key":"10183_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/plants12061217","volume":"12","author":"NB Rathod","year":"2023","unstructured":"Rathod NB, Elabed N, Punia S, Ozogul F, Kim SK, Rocha JM (2023) Recent developments in polyphenol applications on human health: a review with current knowledge. Plants 12(6):1217","journal-title":"Plants"},{"issue":"1","key":"10183_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41495-0","volume":"14","author":"CR Guo","year":"2023","unstructured":"Guo CR, Zhang ZZ, Zhou X, Sun MY, Li TT, Lei YT, Gao YH, Li QQ, Yue CX, Gao Y, Lin YY, Hao CY, Li CZ, Cao P, Zhu MX, Rong MQ, Wang WH, Yu Y (2023) Chronic cough relief by allosteric modulation of P2X3 without taste disturbance. Nat Commun 14(1):5844","journal-title":"Nat Commun"},{"issue":"9","key":"10183_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0204229","volume":"13","author":"E Nuka","year":"2018","unstructured":"Nuka E, Ohnishi K, Terao J, Kawai Y (2018) ATP\/P2X7 receptor signaling as a potential anti-inflammatory target of natural polyphenols. PLoS ONE 13(9):e0204229. https:\/\/doi.org\/10.1371\/journal.pone.0204229","journal-title":"PLoS ONE"},{"issue":"3","key":"10183_CR15","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s11302-012-9314-7","volume":"8","author":"K Kaczmarek-H\u00e1jek","year":"2012","unstructured":"Kaczmarek-H\u00e1jek K, L\u00f6rinczi E, Hausmann R, Nicke A (2012) Molecular and functional properties of P2X receptors recent progress and persisting challenges. Purinergic Signal 8(3):375\u2013417. https:\/\/doi.org\/10.1007\/s11302-012-9314-7","journal-title":"Purinergic Signal"},{"key":"10183_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2023.109503","volume":"230","author":"KA Jacobson","year":"2023","unstructured":"Jacobson KA, Pradhan B, Wen Z, Pramanik A (2023) New paradigms in purinergic receptor ligand discovery. Neuropharmacology 230:109503. https:\/\/doi.org\/10.1016\/j.neuropharm.2023.109503","journal-title":"Neuropharmacology"},{"key":"10183_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113029","volume":"150","author":"CR Dong","year":"2022","unstructured":"Dong CR, Zhang WJ, Luo HL (2022) Association between P2X3 receptors and neuropathic pain: as a potential therapeutic target for therapy. Biomed Pharmacother 150:113029","journal-title":"Biomed Pharmacother"},{"key":"10183_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.925880","volume":"13","author":"AC Oken","year":"2022","unstructured":"Oken AC, Krishnamurthy I, Savage JC, Lisi NE, Godsey MH, Mansoor SE (2022) Molecular pharmacology of P2X receptors: exploring druggable domains revealed by structural biology. Front Pharmacol 13:925880","journal-title":"Front Pharmacol"},{"key":"10183_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1345625","volume":"15","author":"H Zheng","year":"2024","unstructured":"Zheng H, Liu Q, Zhou S, Luo H, Zhang W (2024) Role and therapeutic targets of P2X7 receptors in neurodegenerative diseases. Front Immunol 15:1345625","journal-title":"Front Immunol"},{"key":"10183_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.114205","volume":"158","author":"JP Liu","year":"2023","unstructured":"Liu JP, Liu SC, Hu SQ, Lu JF, Wu CL, Hu DX, Zhang WJ (2023) ATP ion channel P2X purinergic receptors in inflammation response. Biomed Pharmacother 158:114205. https:\/\/doi.org\/10.1016\/j.biopha.2022.114205. (Epub 2023 Jan 4 PMID: 36916431)","journal-title":"Biomed Pharmacother"},{"key":"10183_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.00478","volume":"14","author":"MS Uddin","year":"2020","unstructured":"Uddin MS, Mamun AA, Rahman MA, Kabir MT, Alkahtani S, Alanazi IS, Perveen A, Ashraf GM, Bin-Jumah MN, Abdel-Daim MM (2020) Exploring the promise of flavonoids to combat neuropathic pain: from molecular mechanisms to therapeutic implications. Front Neurosci 14:478. https:\/\/doi.org\/10.3389\/fnins.2020.00478","journal-title":"Front Neurosci"},{"key":"10183_CR22","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.neuropharm.2015.10.031","volume":"104","author":"LT Woods","year":"2016","unstructured":"Woods LT, Ajit D, Camden JM, Erb L, Weisman GA (2016) Purinergic receptors as potential therapeutic targets in Alzheimer\u2019s disease. Neuropharmacology 104:169\u2013179. https:\/\/doi.org\/10.1016\/j.neuropharm.2015.10.031","journal-title":"Neuropharmacology"},{"issue":"3","key":"10183_CR23","doi-asserted-by":"publisher","first-page":"257","DOI":"10.2174\/1871527315666160922104848","volume":"16","author":"G Burnstock","year":"2021","unstructured":"Burnstock G (2021) Purinergic signalling and neurological diseases: an update. CNS Neurol Disord Drug Targets 16(3):257\u2013265. https:\/\/doi.org\/10.2174\/1871527315666160922104848","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"10183_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.781069","volume":"12","author":"Q An","year":"2021","unstructured":"An Q, Yue G, Yang X, Lou J, Shan W, Ding J, Jin Z, Hu Y, Du Q, Liao Q, Xie R, Xu J (2021) Pathophysiological role of purinergic P2X receptors in digestive system diseases. Front Physiol 12:781069. https:\/\/doi.org\/10.3389\/fphys.2021.781069","journal-title":"Front Physiol"},{"key":"10183_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2020.114361","volume":"187","author":"I von K\u00fcgelgen","year":"2021","unstructured":"von K\u00fcgelgen I (2021) Molecular pharmacology of P2Y receptor subtypes. Biochem Pharmacol 187:114361. https:\/\/doi.org\/10.1016\/j.bcp.2020.114361","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"10183_CR26","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s11302-023-09963-w","volume":"20","author":"I von K\u00fcgelgen","year":"2024","unstructured":"von K\u00fcgelgen I (2024) Pharmacological characterization of P2Y receptor subtypes - an update. Purinergic Signal 20(2):99\u2013108. https:\/\/doi.org\/10.1007\/s11302-023-09963-w","journal-title":"Purinergic Signal"},{"key":"10183_CR27","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.pharmthera.2018.04.002","volume":"190","author":"M Rafehi","year":"2018","unstructured":"Rafehi M, M\u00fcller CE (2018) Tools and drugs for uracil nucleotide-activated P2Y receptors. Pharmacol Ther 190:24\u201380. https:\/\/doi.org\/10.1016\/j.pharmthera.2018.04.002","journal-title":"Pharmacol Ther"},{"key":"10183_CR28","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.neuropharm.2015.10.030","volume":"104","author":"I von K\u00fcgelgen","year":"2016","unstructured":"von K\u00fcgelgen I, Hoffmann K (2016) Pharmacology and structure of P2Y receptors. Neuropharmacology 104:50\u201361. https:\/\/doi.org\/10.1016\/j.neuropharm.2015.10.030","journal-title":"Neuropharmacology"},{"issue":"2","key":"10183_CR29","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3109\/09537100903470298","volume":"21","author":"NM Bambace","year":"2010","unstructured":"Bambace NM, Levis JE, Holmes CE (2010) The effect of P2Y-mediated platelet activation on the release of VEGF and endostatin from platelets. Platelets 21(2):85\u201393. https:\/\/doi.org\/10.3109\/09537100903470298. (PMID: 20063989)","journal-title":"Platelets"},{"issue":"6","key":"10183_CR30","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s11302-024-10020-3","volume":"20","author":"PCL Faria","year":"2024","unstructured":"Faria PCL, Resende RS, Cardoso AM (2024) Metastasis and angiogenesis in cervical cancer: key aspects of purinergic signaling in platelets and possible therapeutic targets. Purinergic Signal 20(6):607\u2013616. https:\/\/doi.org\/10.1007\/s11302-024-10020-3","journal-title":"Purinergic Signal"},{"issue":"1","key":"10183_CR31","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.ccr.2013.05.008","volume":"24","author":"D Schumacher","year":"2013","unstructured":"Schumacher D, Strilic B, Sivaraj KK, Wettschureck N, Offermanns S (2013) Platelet-derived nucleotides promote tumor-cell transendothelial migration and metastasis via P2Y2 receptor. Cancer Cell 24(1):130\u2013137. https:\/\/doi.org\/10.1016\/j.ccr.2013.05.008. (Epub 2013 Jun 27 PMID: 23810565)","journal-title":"Cancer Cell"},{"issue":"Pt 22","key":"10183_CR32","doi-asserted-by":"publisher","first-page":"4964","DOI":"10.1242\/jcs.159012","volume":"127","author":"H Campwala","year":"2014","unstructured":"Campwala H, Sexton DW, Crossman DC, Fountain SJ (2014) P2Y\u2086 receptor inhibition perturbs CCL2-evoked signalling in human monocytic and peripheral blood mononuclear cells. J Cell Sci 127(Pt 22):4964\u20134973. https:\/\/doi.org\/10.1242\/jcs.159012","journal-title":"J Cell Sci"},{"issue":"1","key":"10183_CR33","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1136\/gutjnl-2020-320937","volume":"71","author":"M Salem","year":"2022","unstructured":"Salem M, Lecka J, Pelletier J, Gomes Marconato D, Dumas A, Valli\u00e8res L, Brochu G, Robaye B, Jobin C, S\u00e9vigny J (2022) NTPDase8 protects mice from intestinal inflammation by limiting P2Y6 receptor activation: identification of a new pathway of inflammation for the potential treatment of IBD. Gut 71(1):43\u201354. https:\/\/doi.org\/10.1136\/gutjnl-2020-320937. (Epub 2021 Jan 15 PMID: 33452178)","journal-title":"Gut"},{"key":"10183_CR34","doi-asserted-by":"publisher","DOI":"10.1007\/s11302-024-10016-z","author":"MO Dales","year":"2024","unstructured":"Dales MO, Drummond RM, Kennedy C (2024) How selective antagonists and genetic modification have helped characterise the expression and functions of vascular P2Y receptors. Purinergic Signal. https:\/\/doi.org\/10.1007\/s11302-024-10016-z","journal-title":"Purinergic Signal"},{"issue":"2","key":"10183_CR35","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1007\/s12035-013-8577-5","volume":"49","author":"D Ajit","year":"2014","unstructured":"Ajit D, Woods LT, Camden JM, Thebeau CN, El-Sayed FG, Greeson GW, Erb L, Petris MJ, Miller DC, Sun GY, Weisman GA (2014) Loss of P2Y\u2082 nucleotide receptors enhances early pathology in the TgCRND8 mouse model of Alzheimer\u2019s disease. Mol Neurobiol 49(2):1031\u20131042. https:\/\/doi.org\/10.1007\/s12035-013-8577-5","journal-title":"Mol Neurobiol"},{"key":"10183_CR36","doi-asserted-by":"publisher","DOI":"10.1007\/s11302-024-10029-8","author":"SY Mei","year":"2024","unstructured":"Mei SY, Zhang N, Wang MJ, Lv PR, Liu Q (2024) Microglial purinergic signaling in Alzheimer\u2019s disease. Purinergic Signal. https:\/\/doi.org\/10.1007\/s11302-024-10029-8","journal-title":"Purinergic Signal"},{"key":"10183_CR37","doi-asserted-by":"publisher","DOI":"10.1007\/s11302-024-10036-9","author":"AS Shatat","year":"2024","unstructured":"Shatat AS (2024) P2Y11 receptor is a critical regulator of extracellular ATP-mediated premature senescence in lung fibroblasts: implications of ER-Ca+2 release\/mitochondrial ROS production signaling pathway. Purinergic Signal. https:\/\/doi.org\/10.1007\/s11302-024-10036-9","journal-title":"Purinergic Signal"},{"issue":"14","key":"10183_CR38","doi-asserted-by":"publisher","first-page":"11989","DOI":"10.1021\/acs.jmedchem.4c00699","volume":"67","author":"YH Wang","year":"2024","unstructured":"Wang YH, Liu CX, Zhang YH, Yang YL, Zhao Y, Han L, Wang QQ, Xiao W, Hu QH, Ding ZH, Zhou MZ, Jiang C (2024) Discovery of a Series of 4-Amide-thiophene-2-carboxyl Derivatives as Highly Potent P2Y14 Receptor Antagonists for Inflammatory Bowel Disease Treatment. J Med Chem 67(14):11989\u201312011. https:\/\/doi.org\/10.1021\/acs.jmedchem.4c00699. (Epub 2024 Jul 3 PMID: 38959216)","journal-title":"J Med Chem"},{"key":"10183_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2024.111281","author":"S Shukla","year":"2024","unstructured":"Shukla S, Dalai P, Agrawal-Rajput R (2024) Metabolic crosstalk: extracellular ATP and the tumor microenvironment in cancer progression and therapy. Cell Signal. https:\/\/doi.org\/10.1016\/j.cellsig.2024.111281","journal-title":"Cell Signal"},{"key":"10183_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.102137","volume":"47","author":"LEB Savio","year":"2021","unstructured":"Savio LEB, Leite-Aguiar R, Alves VS, Coutinho-Silva R, Wyse ATS (2021) Purinergic signaling in the modulation of redox biology. Redox Biol 47:102137. https:\/\/doi.org\/10.1016\/j.redox.2021.102137","journal-title":"Redox Biol"},{"issue":"9","key":"10183_CR41","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1016\/j.bbagen.2007.06.003","volume":"1770","author":"E Braganhol","year":"2007","unstructured":"Braganhol E, Tamajusuku AS, Bernardi A, Wink MR, Battastini AM (2007) Ecto-5\u2019-nucleotidase\/CD73 inhibition by quercetin in the human U138MG glioma cell line. Biochim Biophys Acta 1770(9):1352\u20131359. https:\/\/doi.org\/10.1016\/j.bbagen.2007.06.003","journal-title":"Biochim Biophys Acta"},{"issue":"15","key":"10183_CR42","doi-asserted-by":"publisher","first-page":"1366197","DOI":"10.3389\/fimmu.2024.1366197.PMID:38601156;PMCID:PMC11004431","volume":"27","author":"K Mediratta","year":"2024","unstructured":"Mediratta K, El-Sahli S, Marotel M, Awan MZ, Kirkby M, Salkini A, Kurdieh R, Abdisalam S, Shrestha A, Di Censo C, Sulaiman A, McGarry S, Lavoie JR, Liu Z, Lee SH, Li X, Scium\u00e8 G, D\u2019Costa VM, Ardolino M, Wang L (2024) Targeting CD73 with flavonoids inhibits cancer stem cells and increases lymphocyte infiltration in a triple-negative breast cancer mouse model. Front Immunol 27(15):1366197. https:\/\/doi.org\/10.3389\/fimmu.2024.1366197.PMID:38601156;PMCID:PMC11004431","journal-title":"Front Immunol"},{"issue":"6","key":"10183_CR43","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.202000777","volume":"65","author":"B Ozyel","year":"2021","unstructured":"Ozyel B, Le Gall G, Needs PW, Kroon PA (2021) Anti-inflammatory effects of quercetin on high-glucose and pro-inflammatory cytokine challenged vascular endothelial cell metabolism. Mol Nutr Food Res 65(6):e2000777. https:\/\/doi.org\/10.1002\/mnfr.202000777","journal-title":"Mol Nutr Food Res"},{"issue":"7","key":"10183_CR44","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/j.urolonc.2011.10.009","volume":"31","author":"L Rockenbach","year":"2013","unstructured":"Rockenbach L, Bavaresco L, Fernandes Farias P, Cappellari AR, Barrios CH, Bueno Morrone F, Oliveira Battastini AM (2013) Alterations in the extracellular catabolism of nucleotides are involved in the antiproliferative effect of quercetin in human bladder cancer T24 cells. Urol Oncol 31(7):1204\u20131211. https:\/\/doi.org\/10.1016\/j.urolonc.2011.10.009","journal-title":"Urol Oncol"},{"key":"10183_CR45","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1016\/j.biopha.2016.10.109","volume":"84","author":"J Baldissarelli","year":"2016","unstructured":"Baldissarelli J, Santi A, Schmatz R, Zanini D, Cardoso AM, Abadalla FH, Thom\u00e9 GR, Murussi C, Polachini CRN, Delenogare DP, Loro VL, Morsch VM, Schetinger MRC (2016) Quercetin changes purinergic enzyme activities and oxidative profile in platelets of rats with hypothyroidism. Biomed Pharmacother 84:1849\u20131857. https:\/\/doi.org\/10.1016\/j.biopha.2016.10.109. (Epub 2016 Nov 7 PMID: 27832996)","journal-title":"Biomed Pharmacother"},{"key":"10183_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113128","volume":"151","author":"CF Wu","year":"2022","unstructured":"Wu CF, Wu CY, Lin CF, Liu YW, Lin TC, Liao HJ, Chang GR (2022) The anticancer effects of cyanidin 3-O-glucoside combined with 5-fluorouracil on lung large-cell carcinoma in nude mice. Biomed Pharmacother 151:113128. https:\/\/doi.org\/10.1016\/j.biopha.2022.113128","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"10183_CR47","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1039\/c5fo00871a","volume":"7","author":"Y Chtourou","year":"2016","unstructured":"Chtourou Y, Kamoun Z, Zarrouk W, Kebieche M, Kallel C, Gdoura R, Fetoui H (2016) Naringenin ameliorates renal and platelet purinergic signalling alterations in high-cholesterol fed rats through the suppression of ROS and NF-\u03baB signaling pathways. Food Funct 7(1):183\u2013193. https:\/\/doi.org\/10.1039\/c5fo00871a","journal-title":"Food Funct"},{"issue":"22","key":"10183_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25225243","volume":"25","author":"A Ullah","year":"2020","unstructured":"Ullah A, Munir S, Badshah SL, Khan N, Ghani L, Poulson BG, Emwas AH, Jaremko M (2020) Important flavonoids and their role as a therapeutic agent. Molecules 25(22):5243. https:\/\/doi.org\/10.3390\/molecules25225243","journal-title":"Molecules"},{"key":"10183_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.fitote.2020.104709","volume":"146","author":"PAF Pacheco","year":"2020","unstructured":"Pacheco PAF, Diogo RT, Magalh\u00e3es BQ, Faria RX (2020) Plant natural products as source of new P2 receptors ligands. Fitoterapia 146:104709. https:\/\/doi.org\/10.1016\/j.fitote.2020.104709. (Epub 2020 Aug 20 PMID: 32829014)","journal-title":"Fitoterapia"},{"issue":"16","key":"10183_CR50","doi-asserted-by":"publisher","first-page":"8939","DOI":"10.3390\/ijms22168939.PMID:34445644;PMCID:PMC8396326","volume":"22","author":"A Cano-Mart\u00ednez","year":"2021","unstructured":"Cano-Mart\u00ednez A, Bautista-P\u00e9rez R, Castrej\u00f3n-T\u00e9llez V, Carre\u00f3n-Torres E, P\u00e9rez-Torres I, D\u00edaz-D\u00edaz E, Flores-Estrada J, Guarner-Lans V, Rubio-Ru\u00edz ME (2021) Resveratrol and Quercetin as Regulators of Inflammatory and Purinergic Receptors to Attenuate Liver Damage Associated to Metabolic Syndrome. Int J Mol Sci 22(16):8939. https:\/\/doi.org\/10.3390\/ijms22168939.PMID:34445644;PMCID:PMC8396326","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10183_CR51","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1111\/j.1476-5381.2009.00596.x","volume":"159","author":"RD And\u00f3","year":"2010","unstructured":"And\u00f3 RD, M\u00e9h\u00e9sz B, Gyires K, Illes P, Sperl\u00e1gh B (2010) A comparative analysis of the activity of ligands acting at P2X and P2Y receptor subtypes in models of neuropathic, acute and inflammatory pain. Br J Pharmacol 159(5):1106\u20131117. https:\/\/doi.org\/10.1111\/j.1476-5381.2009.00596.x","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10183_CR52","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.neuron.2012.09.024","volume":"76","author":"BS Khakh","year":"2012","unstructured":"Khakh BS, North RA (2012) Neuromodulation by extracellular ATP and P2X receptors in the CNS. Neuron 76(1):51\u201369. https:\/\/doi.org\/10.1016\/j.neuron.2012.09.024","journal-title":"Neuron"},{"issue":"16","key":"10183_CR53","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.21037\/atm-21-3423","volume":"9","author":"H Li","year":"2021","unstructured":"Li H, Bai F, Cong C, Chen B, Xie W, Li S, Liu Q, Chen C, Wu Y (2021) Effects of ligustrazine on the expression of neurotransmitters in the trigeminal ganglion of a rat migraine model. Ann Transl Med 9(16):1318. https:\/\/doi.org\/10.21037\/atm-21-3423","journal-title":"Ann Transl Med"},{"key":"10183_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.820071","volume":"13","author":"J Li","year":"2022","unstructured":"Li J, Gong X (2022) Tetramethylpyrazine: an active ingredient of Chinese herbal medicine with therapeutic potential in acute kidney injury and renal fibrosis. Front Pharmacol 13:820071. https:\/\/doi.org\/10.3389\/fphar.2022.820071","journal-title":"Front Pharmacol"},{"key":"10183_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/s13020-020-00370-6","volume":"15","author":"H Xiang","year":"2020","unstructured":"Xiang H, Zuo J, Guo F, Dong D (2020) What we already know about rhubarb: a comprehensive review. Chin Med 15:88. https:\/\/doi.org\/10.1186\/s13020-020-00370-6","journal-title":"Chin Med"},{"key":"10183_CR56","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.cofs.2016.02.002","volume":"8","author":"H Zhang","year":"2016","unstructured":"Zhang H, Tsao R (2016) Dietary polyphenols, oxidative stress and antioxidant and anti-inflammatory effects. Curr Opin Food Sci 8:33\u201342","journal-title":"Curr Opin Food Sci"},{"issue":"1","key":"10183_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/jhn.12177","volume":"27","author":"AB Santhakumar","year":"2014","unstructured":"Santhakumar AB, Bulmer AC, Singh I (2014) A review of the mechanisms and effectiveness of dietary polyphenols in reducing oxidative stress and thrombotic risk. J Hum Nutr Diet 27(1):1\u201321. https:\/\/doi.org\/10.1111\/jhn.12177","journal-title":"J Hum Nutr Diet"},{"issue":"14","key":"10183_CR58","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25147530","volume":"25","author":"MR Ki","year":"2024","unstructured":"Ki MR, Youn S, Kim DH, Pack SP (2024) Natural compounds for preventing age-related diseases and cancers. Int J Mol Sci 25(14):7530. https:\/\/doi.org\/10.3390\/ijms25147530","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10183_CR59","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20061428","volume":"20","author":"MC Kang","year":"2019","unstructured":"Kang MC, Cho K, Lee JH, Subedi L, Yumnam S, Kim SY (2019) Effect of resveratrol-enriched rice on skin inflammation and pruritus in the NC\/Nga mouse model of atopic dermatitis. Int J Mol Sci 20(6):1428. https:\/\/doi.org\/10.3390\/ijms20061428","journal-title":"Int J Mol Sci"},{"key":"10183_CR60","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s11302-021-09821-7","volume":"18","author":"GB da Silva","year":"2022","unstructured":"da Silva GB, Yamauchi MA, Zanini D, Bagatini MD (2022) Novel possibility for cutaneous melanoma treatment by means of rosmarinic acid action on purinergic signaling. Purinergic Signal 18:61\u201381","journal-title":"Purinergic Signal"},{"issue":"11","key":"10183_CR61","doi-asserted-by":"publisher","first-page":"4011","DOI":"10.1016\/j.apsb.2022.08.022","volume":"12","author":"Y Zhu","year":"2022","unstructured":"Zhu Y, Ouyang Z, Du H, Wang M, Wang J, Sun H, Kong L, Xu Q, Ma H, Sun Y (2022) New opportunities and challenges of natural products research: when target identification meets single-cell multiomics. Acta Pharm Sin B 12(11):4011\u20134039. https:\/\/doi.org\/10.1016\/j.apsb.2022.08.022","journal-title":"Acta Pharm Sin B"},{"issue":"5","key":"10183_CR62","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.3390\/molecules30051184","volume":"30","author":"L Hu","year":"2025","unstructured":"Hu L, Luo Y, Yang J, Cheng C (2025) Botanical flavonoids: efficacy, absorption, metabolism and advanced pharmaceutical technology for improving bioavailability. Molecules 30(5):1184. https:\/\/doi.org\/10.3390\/molecules30051184","journal-title":"Molecules"},{"issue":"5","key":"10183_CR63","doi-asserted-by":"publisher","DOI":"10.3390\/bioengineering9050197","volume":"9","author":"M Ferreira","year":"2022","unstructured":"Ferreira M, Costa D, Sousa A (2022) Flavonoids-based delivery systems towards cancer therapies. Bioengineering (Basel) 9(5):197. https:\/\/doi.org\/10.3390\/bioengineering9050197","journal-title":"Bioengineering (Basel)"}],"container-title":["Purinergic Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11302-026-10183-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11302-026-10183-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11302-026-10183-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T03:38:15Z","timestamp":1789616295000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11302-026-10183-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,17]]},"references-count":63,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10183"],"URL":"https:\/\/doi.org\/10.1007\/s11302-026-10183-1","relation":{},"ISSN":["1573-9538","1573-9546"],"issn-type":[{"value":"1573-9538","type":"print"},{"value":"1573-9546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,17]]},"assertion":[{"value":"25 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"It is a review article. So, no ethical approval and no consent from participants are required.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors have read and approved the final version of the manuscript. The authors declare that this manuscript has not been sent for publication in any other journal.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}}],"article-number":"72"}}